Active Pharmaceutical Ingredients (API) Industry Research Report 2024
An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
According to APO Research, The global Active Pharmaceutical Ingredients (API) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson & Johnson are the top 5 manufacturers of industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Active Pharmaceutical Ingredients (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Pharmaceutical Ingredients (API).
The report will help the Active Pharmaceutical Ingredients (API) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Active Pharmaceutical Ingredients (API) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Active Pharmaceutical Ingredients (API) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Active Pharmaceutical Ingredients (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Active Pharmaceutical Ingredients (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Active Pharmaceutical Ingredients (API).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Active Pharmaceutical Ingredients (API) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Active Pharmaceutical Ingredients (API) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Active Pharmaceutical Ingredients (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
According to APO Research, The global Active Pharmaceutical Ingredients (API) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson & Johnson are the top 5 manufacturers of industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Active Pharmaceutical Ingredients (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Pharmaceutical Ingredients (API).
The report will help the Active Pharmaceutical Ingredients (API) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Active Pharmaceutical Ingredients (API) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Active Pharmaceutical Ingredients (API) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Teva
- Mylan
- DSM
- Aurobindo Pharma
- Aspen
- Novartis
- BASF
- Pfizer
- Huahai Pharmaceutical
- Hisun Pharmaceutical
- Sun Pharmaceutical Industries
- Zhejiang Medicine
- Dr. Reddy’s Laboratories
- Zhejiang NHU
- Bayer
- NCPC
- AbbVie
- Shandong Xinhua Pharmaceutical
- Northeast Pharm
- Harbin Pharmaceutical
- LKPC
- Synthetic APIs
- Biotech APIs
- CNS
- Cardiovascular
- Genitourinary/Hormonal Drugs
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Active Pharmaceutical Ingredients (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Active Pharmaceutical Ingredients (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Active Pharmaceutical Ingredients (API).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Active Pharmaceutical Ingredients (API) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Active Pharmaceutical Ingredients (API) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Active Pharmaceutical Ingredients (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Active Pharmaceutical Ingredients (API) by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.2.2 Synthetic APIs
2.2.3 Biotech APIs
2.3 Active Pharmaceutical Ingredients (API) by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 CNS
2.3.3 Cardiovascular
2.3.4 Genitourinary/Hormonal Drugs
2.3.5 Respiratory
2.3.6 Rheumatology
2.3.7 Diabetes
2.3.8 Oncology
2.3.9 Others
2.4 Global Market Growth Prospects
2.4.1 Global Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)
2.4.2 Global Active Pharmaceutical Ingredients (API) Production Capacity Estimates and Forecasts (2019-2030)
2.4.3 Global Active Pharmaceutical Ingredients (API) Production Estimates and Forecasts (2019-2030)
2.4.4 Global Active Pharmaceutical Ingredients (API) Market Average Price (2019-2030)
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Active Pharmaceutical Ingredients (API) Production by Manufacturers (2019-2024)
3.2 Global Active Pharmaceutical Ingredients (API) Production Value by Manufacturers (2019-2024)
3.3 Global Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2019-2024)
3.4 Global Active Pharmaceutical Ingredients (API) Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Active Pharmaceutical Ingredients (API) Key Manufacturers, Manufacturing Sites & Headquarters
3.6 Global Active Pharmaceutical Ingredients (API) Manufacturers, Product Type & Application
3.7 Global Active Pharmaceutical Ingredients (API) Manufacturers, Date of Enter into This Industry
3.8 Global Active Pharmaceutical Ingredients (API) Market CR5 and HHI
3.9 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Teva
4.1.1 Teva Active Pharmaceutical Ingredients (API) Company Information
4.1.2 Teva Active Pharmaceutical Ingredients (API) Business Overview
4.1.3 Teva Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.1.4 Teva Product Portfolio
4.1.5 Teva Recent Developments
4.2 Mylan
4.2.1 Mylan Active Pharmaceutical Ingredients (API) Company Information
4.2.2 Mylan Active Pharmaceutical Ingredients (API) Business Overview
4.2.3 Mylan Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.2.4 Mylan Product Portfolio
4.2.5 Mylan Recent Developments
4.3 DSM
4.3.1 DSM Active Pharmaceutical Ingredients (API) Company Information
4.3.2 DSM Active Pharmaceutical Ingredients (API) Business Overview
4.3.3 DSM Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.3.4 DSM Product Portfolio
4.3.5 DSM Recent Developments
4.4 Aurobindo Pharma
4.4.1 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Company Information
4.4.2 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Business Overview
4.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.4.4 Aurobindo Pharma Product Portfolio
4.4.5 Aurobindo Pharma Recent Developments
4.5 Aspen
4.5.1 Aspen Active Pharmaceutical Ingredients (API) Company Information
4.5.2 Aspen Active Pharmaceutical Ingredients (API) Business Overview
4.5.3 Aspen Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.5.4 Aspen Product Portfolio
4.5.5 Aspen Recent Developments
4.6 Novartis
4.6.1 Novartis Active Pharmaceutical Ingredients (API) Company Information
4.6.2 Novartis Active Pharmaceutical Ingredients (API) Business Overview
4.6.3 Novartis Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.6.4 Novartis Product Portfolio
4.6.5 Novartis Recent Developments
4.7 BASF
4.7.1 BASF Active Pharmaceutical Ingredients (API) Company Information
4.7.2 BASF Active Pharmaceutical Ingredients (API) Business Overview
4.7.3 BASF Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.7.4 BASF Product Portfolio
4.7.5 BASF Recent Developments
4.8 Pfizer
4.8.1 Pfizer Active Pharmaceutical Ingredients (API) Company Information
4.8.2 Pfizer Active Pharmaceutical Ingredients (API) Business Overview
4.8.3 Pfizer Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.8.4 Pfizer Product Portfolio
4.8.5 Pfizer Recent Developments
4.9 Huahai Pharmaceutical
4.9.1 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Company Information
4.9.2 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Business Overview
4.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.9.4 Huahai Pharmaceutical Product Portfolio
4.9.5 Huahai Pharmaceutical Recent Developments
4.10 Hisun Pharmaceutical
4.10.1 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Company Information
4.10.2 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Business Overview
4.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.10.4 Hisun Pharmaceutical Product Portfolio
4.10.5 Hisun Pharmaceutical Recent Developments
4.11 Sun Pharmaceutical Industries
4.11.1 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Company Information
4.11.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Business Overview
4.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.11.4 Sun Pharmaceutical Industries Product Portfolio
4.11.5 Sun Pharmaceutical Industries Recent Developments
4.12 Zhejiang Medicine
4.12.1 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Company Information
4.12.2 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Business Overview
4.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.12.4 Zhejiang Medicine Product Portfolio
4.12.5 Zhejiang Medicine Recent Developments
4.13 Dr. Reddy’s Laboratories
4.13.1 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Company Information
4.13.2 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Business Overview
4.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.13.4 Dr. Reddy’s Laboratories Product Portfolio
4.13.5 Dr. Reddy’s Laboratories Recent Developments
4.14 Zhejiang NHU
4.14.1 Zhejiang NHU Active Pharmaceutical Ingredients (API) Company Information
4.14.2 Zhejiang NHU Active Pharmaceutical Ingredients (API) Business Overview
4.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.14.4 Zhejiang NHU Product Portfolio
4.14.5 Zhejiang NHU Recent Developments
4.15 Bayer
4.15.1 Bayer Active Pharmaceutical Ingredients (API) Company Information
4.15.2 Bayer Active Pharmaceutical Ingredients (API) Business Overview
4.15.3 Bayer Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.15.4 Bayer Product Portfolio
4.15.5 Bayer Recent Developments
4.16 NCPC
4.16.1 NCPC Active Pharmaceutical Ingredients (API) Company Information
4.16.2 NCPC Active Pharmaceutical Ingredients (API) Business Overview
4.16.3 NCPC Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.16.4 NCPC Product Portfolio
4.16.5 NCPC Recent Developments
4.17 AbbVie
4.17.1 AbbVie Active Pharmaceutical Ingredients (API) Company Information
4.17.2 AbbVie Active Pharmaceutical Ingredients (API) Business Overview
4.17.3 AbbVie Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.17.4 AbbVie Product Portfolio
4.17.5 AbbVie Recent Developments
4.18 Shandong Xinhua Pharmaceutical
4.18.1 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Company Information
4.18.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Business Overview
4.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.18.4 Shandong Xinhua Pharmaceutical Product Portfolio
4.18.5 Shandong Xinhua Pharmaceutical Recent Developments
4.19 Northeast Pharm
4.19.1 Northeast Pharm Active Pharmaceutical Ingredients (API) Company Information
4.19.2 Northeast Pharm Active Pharmaceutical Ingredients (API) Business Overview
4.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.19.4 Northeast Pharm Product Portfolio
4.19.5 Northeast Pharm Recent Developments
4.20 Harbin Pharmaceutical
4.20.1 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Company Information
4.20.2 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Business Overview
4.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.20.4 Harbin Pharmaceutical Product Portfolio
4.20.5 Harbin Pharmaceutical Recent Developments
4.21 LKPC
4.21.1 LKPC Active Pharmaceutical Ingredients (API) Company Information
4.21.2 LKPC Active Pharmaceutical Ingredients (API) Business Overview
4.21.3 LKPC Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.21.4 LKPC Product Portfolio
4.21.5 LKPC Recent Developments
5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) PRODUCTION BY REGION
5.1 Global Active Pharmaceutical Ingredients (API) Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
5.2 Global Active Pharmaceutical Ingredients (API) Production by Region: 2019-2030
5.2.1 Global Active Pharmaceutical Ingredients (API) Production by Region: 2019-2024
5.2.2 Global Active Pharmaceutical Ingredients (API) Production Forecast by Region (2025-2030)
5.3 Global Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
5.4 Global Active Pharmaceutical Ingredients (API) Production Value by Region: 2019-2030
5.4.1 Global Active Pharmaceutical Ingredients (API) Production Value by Region: 2019-2024
5.4.2 Global Active Pharmaceutical Ingredients (API) Production Value Forecast by Region (2025-2030)
5.5 Global Active Pharmaceutical Ingredients (API) Market Price Analysis by Region (2019-2024)
5.6 Global Active Pharmaceutical Ingredients (API) Production and Value, YOY Growth
5.6.1 North America Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)
5.6.2 Europe Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)
5.6.3 China Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)
5.6.4 Japan Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)
5.6.5 India Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)
6 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) CONSUMPTION BY REGION
6.1 Global Active Pharmaceutical Ingredients (API) Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
6.2 Global Active Pharmaceutical Ingredients (API) Consumption by Region (2019-2030)
6.2.1 Global Active Pharmaceutical Ingredients (API) Consumption by Region: 2019-2030
6.2.2 Global Active Pharmaceutical Ingredients (API) Forecasted Consumption by Region (2025-2030)
6.3 North America
6.3.1 North America Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Russia
6.5 Asia Pacific
6.5.1 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 China Taiwan
6.5.7 Southeast Asia
6.5.8 India
6.5.9 Australia
6.6 Latin America, Middle East & Africa
6.6.1 Latin America, Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 Latin America, Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.5 GCC Countries
7 SEGMENT BY TYPE
7.1 Global Active Pharmaceutical Ingredients (API) Production by Type (2019-2030)
7.1.1 Global Active Pharmaceutical Ingredients (API) Production by Type (2019-2030) & (Tons)
7.1.2 Global Active Pharmaceutical Ingredients (API) Production Market Share by Type (2019-2030)
7.2 Global Active Pharmaceutical Ingredients (API) Production Value by Type (2019-2030)
7.2.1 Global Active Pharmaceutical Ingredients (API) Production Value by Type (2019-2030) & (US$ Million)
7.2.2 Global Active Pharmaceutical Ingredients (API) Production Value Market Share by Type (2019-2030)
7.3 Global Active Pharmaceutical Ingredients (API) Price by Type (2019-2030)
8 SEGMENT BY APPLICATION
8.1 Global Active Pharmaceutical Ingredients (API) Production by Application (2019-2030)
8.1.1 Global Active Pharmaceutical Ingredients (API) Production by Application (2019-2030) & (Tons)
8.1.2 Global Active Pharmaceutical Ingredients (API) Production by Application (2019-2030) & (Tons)
8.2 Global Active Pharmaceutical Ingredients (API) Production Value by Application (2019-2030)
8.2.1 Global Active Pharmaceutical Ingredients (API) Production Value by Application (2019-2030) & (US$ Million)
8.2.2 Global Active Pharmaceutical Ingredients (API) Production Value Market Share by Application (2019-2030)
8.3 Global Active Pharmaceutical Ingredients (API) Price by Application (2019-2030)
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
9.1 Active Pharmaceutical Ingredients (API) Value Chain Analysis
9.1.1 Active Pharmaceutical Ingredients (API) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Active Pharmaceutical Ingredients (API) Production Mode & Process
9.2 Active Pharmaceutical Ingredients (API) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Active Pharmaceutical Ingredients (API) Distributors
9.2.3 Active Pharmaceutical Ingredients (API) Customers
10 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) ANALYZING MARKET DYNAMICS
10.1 Active Pharmaceutical Ingredients (API) Industry Trends
10.2 Active Pharmaceutical Ingredients (API) Industry Drivers
10.3 Active Pharmaceutical Ingredients (API) Industry Opportunities and Challenges
10.4 Active Pharmaceutical Ingredients (API) Industry Restraints
11 REPORT CONCLUSION
12 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Active Pharmaceutical Ingredients (API) by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.2.2 Synthetic APIs
2.2.3 Biotech APIs
2.3 Active Pharmaceutical Ingredients (API) by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 CNS
2.3.3 Cardiovascular
2.3.4 Genitourinary/Hormonal Drugs
2.3.5 Respiratory
2.3.6 Rheumatology
2.3.7 Diabetes
2.3.8 Oncology
2.3.9 Others
2.4 Global Market Growth Prospects
2.4.1 Global Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)
2.4.2 Global Active Pharmaceutical Ingredients (API) Production Capacity Estimates and Forecasts (2019-2030)
2.4.3 Global Active Pharmaceutical Ingredients (API) Production Estimates and Forecasts (2019-2030)
2.4.4 Global Active Pharmaceutical Ingredients (API) Market Average Price (2019-2030)
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Active Pharmaceutical Ingredients (API) Production by Manufacturers (2019-2024)
3.2 Global Active Pharmaceutical Ingredients (API) Production Value by Manufacturers (2019-2024)
3.3 Global Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2019-2024)
3.4 Global Active Pharmaceutical Ingredients (API) Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Active Pharmaceutical Ingredients (API) Key Manufacturers, Manufacturing Sites & Headquarters
3.6 Global Active Pharmaceutical Ingredients (API) Manufacturers, Product Type & Application
3.7 Global Active Pharmaceutical Ingredients (API) Manufacturers, Date of Enter into This Industry
3.8 Global Active Pharmaceutical Ingredients (API) Market CR5 and HHI
3.9 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Teva
4.1.1 Teva Active Pharmaceutical Ingredients (API) Company Information
4.1.2 Teva Active Pharmaceutical Ingredients (API) Business Overview
4.1.3 Teva Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.1.4 Teva Product Portfolio
4.1.5 Teva Recent Developments
4.2 Mylan
4.2.1 Mylan Active Pharmaceutical Ingredients (API) Company Information
4.2.2 Mylan Active Pharmaceutical Ingredients (API) Business Overview
4.2.3 Mylan Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.2.4 Mylan Product Portfolio
4.2.5 Mylan Recent Developments
4.3 DSM
4.3.1 DSM Active Pharmaceutical Ingredients (API) Company Information
4.3.2 DSM Active Pharmaceutical Ingredients (API) Business Overview
4.3.3 DSM Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.3.4 DSM Product Portfolio
4.3.5 DSM Recent Developments
4.4 Aurobindo Pharma
4.4.1 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Company Information
4.4.2 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Business Overview
4.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.4.4 Aurobindo Pharma Product Portfolio
4.4.5 Aurobindo Pharma Recent Developments
4.5 Aspen
4.5.1 Aspen Active Pharmaceutical Ingredients (API) Company Information
4.5.2 Aspen Active Pharmaceutical Ingredients (API) Business Overview
4.5.3 Aspen Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.5.4 Aspen Product Portfolio
4.5.5 Aspen Recent Developments
4.6 Novartis
4.6.1 Novartis Active Pharmaceutical Ingredients (API) Company Information
4.6.2 Novartis Active Pharmaceutical Ingredients (API) Business Overview
4.6.3 Novartis Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.6.4 Novartis Product Portfolio
4.6.5 Novartis Recent Developments
4.7 BASF
4.7.1 BASF Active Pharmaceutical Ingredients (API) Company Information
4.7.2 BASF Active Pharmaceutical Ingredients (API) Business Overview
4.7.3 BASF Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.7.4 BASF Product Portfolio
4.7.5 BASF Recent Developments
4.8 Pfizer
4.8.1 Pfizer Active Pharmaceutical Ingredients (API) Company Information
4.8.2 Pfizer Active Pharmaceutical Ingredients (API) Business Overview
4.8.3 Pfizer Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.8.4 Pfizer Product Portfolio
4.8.5 Pfizer Recent Developments
4.9 Huahai Pharmaceutical
4.9.1 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Company Information
4.9.2 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Business Overview
4.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.9.4 Huahai Pharmaceutical Product Portfolio
4.9.5 Huahai Pharmaceutical Recent Developments
4.10 Hisun Pharmaceutical
4.10.1 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Company Information
4.10.2 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Business Overview
4.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.10.4 Hisun Pharmaceutical Product Portfolio
4.10.5 Hisun Pharmaceutical Recent Developments
4.11 Sun Pharmaceutical Industries
4.11.1 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Company Information
4.11.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Business Overview
4.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.11.4 Sun Pharmaceutical Industries Product Portfolio
4.11.5 Sun Pharmaceutical Industries Recent Developments
4.12 Zhejiang Medicine
4.12.1 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Company Information
4.12.2 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Business Overview
4.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.12.4 Zhejiang Medicine Product Portfolio
4.12.5 Zhejiang Medicine Recent Developments
4.13 Dr. Reddy’s Laboratories
4.13.1 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Company Information
4.13.2 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Business Overview
4.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.13.4 Dr. Reddy’s Laboratories Product Portfolio
4.13.5 Dr. Reddy’s Laboratories Recent Developments
4.14 Zhejiang NHU
4.14.1 Zhejiang NHU Active Pharmaceutical Ingredients (API) Company Information
4.14.2 Zhejiang NHU Active Pharmaceutical Ingredients (API) Business Overview
4.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.14.4 Zhejiang NHU Product Portfolio
4.14.5 Zhejiang NHU Recent Developments
4.15 Bayer
4.15.1 Bayer Active Pharmaceutical Ingredients (API) Company Information
4.15.2 Bayer Active Pharmaceutical Ingredients (API) Business Overview
4.15.3 Bayer Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.15.4 Bayer Product Portfolio
4.15.5 Bayer Recent Developments
4.16 NCPC
4.16.1 NCPC Active Pharmaceutical Ingredients (API) Company Information
4.16.2 NCPC Active Pharmaceutical Ingredients (API) Business Overview
4.16.3 NCPC Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.16.4 NCPC Product Portfolio
4.16.5 NCPC Recent Developments
4.17 AbbVie
4.17.1 AbbVie Active Pharmaceutical Ingredients (API) Company Information
4.17.2 AbbVie Active Pharmaceutical Ingredients (API) Business Overview
4.17.3 AbbVie Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.17.4 AbbVie Product Portfolio
4.17.5 AbbVie Recent Developments
4.18 Shandong Xinhua Pharmaceutical
4.18.1 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Company Information
4.18.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Business Overview
4.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.18.4 Shandong Xinhua Pharmaceutical Product Portfolio
4.18.5 Shandong Xinhua Pharmaceutical Recent Developments
4.19 Northeast Pharm
4.19.1 Northeast Pharm Active Pharmaceutical Ingredients (API) Company Information
4.19.2 Northeast Pharm Active Pharmaceutical Ingredients (API) Business Overview
4.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.19.4 Northeast Pharm Product Portfolio
4.19.5 Northeast Pharm Recent Developments
4.20 Harbin Pharmaceutical
4.20.1 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Company Information
4.20.2 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Business Overview
4.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.20.4 Harbin Pharmaceutical Product Portfolio
4.20.5 Harbin Pharmaceutical Recent Developments
4.21 LKPC
4.21.1 LKPC Active Pharmaceutical Ingredients (API) Company Information
4.21.2 LKPC Active Pharmaceutical Ingredients (API) Business Overview
4.21.3 LKPC Active Pharmaceutical Ingredients (API) Production Capacity, Value and Gross Margin (2019-2024)
4.21.4 LKPC Product Portfolio
4.21.5 LKPC Recent Developments
5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) PRODUCTION BY REGION
5.1 Global Active Pharmaceutical Ingredients (API) Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
5.2 Global Active Pharmaceutical Ingredients (API) Production by Region: 2019-2030
5.2.1 Global Active Pharmaceutical Ingredients (API) Production by Region: 2019-2024
5.2.2 Global Active Pharmaceutical Ingredients (API) Production Forecast by Region (2025-2030)
5.3 Global Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
5.4 Global Active Pharmaceutical Ingredients (API) Production Value by Region: 2019-2030
5.4.1 Global Active Pharmaceutical Ingredients (API) Production Value by Region: 2019-2024
5.4.2 Global Active Pharmaceutical Ingredients (API) Production Value Forecast by Region (2025-2030)
5.5 Global Active Pharmaceutical Ingredients (API) Market Price Analysis by Region (2019-2024)
5.6 Global Active Pharmaceutical Ingredients (API) Production and Value, YOY Growth
5.6.1 North America Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)
5.6.2 Europe Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)
5.6.3 China Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)
5.6.4 Japan Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)
5.6.5 India Active Pharmaceutical Ingredients (API) Production Value Estimates and Forecasts (2019-2030)
6 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) CONSUMPTION BY REGION
6.1 Global Active Pharmaceutical Ingredients (API) Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
6.2 Global Active Pharmaceutical Ingredients (API) Consumption by Region (2019-2030)
6.2.1 Global Active Pharmaceutical Ingredients (API) Consumption by Region: 2019-2030
6.2.2 Global Active Pharmaceutical Ingredients (API) Forecasted Consumption by Region (2025-2030)
6.3 North America
6.3.1 North America Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Russia
6.5 Asia Pacific
6.5.1 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 China Taiwan
6.5.7 Southeast Asia
6.5.8 India
6.5.9 Australia
6.6 Latin America, Middle East & Africa
6.6.1 Latin America, Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 Latin America, Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.5 GCC Countries
7 SEGMENT BY TYPE
7.1 Global Active Pharmaceutical Ingredients (API) Production by Type (2019-2030)
7.1.1 Global Active Pharmaceutical Ingredients (API) Production by Type (2019-2030) & (Tons)
7.1.2 Global Active Pharmaceutical Ingredients (API) Production Market Share by Type (2019-2030)
7.2 Global Active Pharmaceutical Ingredients (API) Production Value by Type (2019-2030)
7.2.1 Global Active Pharmaceutical Ingredients (API) Production Value by Type (2019-2030) & (US$ Million)
7.2.2 Global Active Pharmaceutical Ingredients (API) Production Value Market Share by Type (2019-2030)
7.3 Global Active Pharmaceutical Ingredients (API) Price by Type (2019-2030)
8 SEGMENT BY APPLICATION
8.1 Global Active Pharmaceutical Ingredients (API) Production by Application (2019-2030)
8.1.1 Global Active Pharmaceutical Ingredients (API) Production by Application (2019-2030) & (Tons)
8.1.2 Global Active Pharmaceutical Ingredients (API) Production by Application (2019-2030) & (Tons)
8.2 Global Active Pharmaceutical Ingredients (API) Production Value by Application (2019-2030)
8.2.1 Global Active Pharmaceutical Ingredients (API) Production Value by Application (2019-2030) & (US$ Million)
8.2.2 Global Active Pharmaceutical Ingredients (API) Production Value Market Share by Application (2019-2030)
8.3 Global Active Pharmaceutical Ingredients (API) Price by Application (2019-2030)
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
9.1 Active Pharmaceutical Ingredients (API) Value Chain Analysis
9.1.1 Active Pharmaceutical Ingredients (API) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Active Pharmaceutical Ingredients (API) Production Mode & Process
9.2 Active Pharmaceutical Ingredients (API) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Active Pharmaceutical Ingredients (API) Distributors
9.2.3 Active Pharmaceutical Ingredients (API) Customers
10 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) ANALYZING MARKET DYNAMICS
10.1 Active Pharmaceutical Ingredients (API) Industry Trends
10.2 Active Pharmaceutical Ingredients (API) Industry Drivers
10.3 Active Pharmaceutical Ingredients (API) Industry Opportunities and Challenges
10.4 Active Pharmaceutical Ingredients (API) Industry Restraints
11 REPORT CONCLUSION
12 DISCLAIMER
